Finding your niche: immune evasion in quiescent tumor reservoirs

Trends Immunol. 2022 Jul;43(7):500-502. doi: 10.1016/j.it.2022.05.003. Epub 2022 Jun 5.

Abstract

Emerging immunotherapies offer a new hope for cancer patients but are not always effective even when a tumor is recognized by the immune system. Baldominos and colleagues address this challenge by characterizing a resilient niche of metabolically unique quiescent cancer cells (QCCs) that resist T cell-mediated control.

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Humans
  • Immune Evasion*
  • Immunotherapy
  • Neoplasms*
  • T-Lymphocytes
  • Tumor Microenvironment